Recent research suggests that there may be different types of preeclampsia (such as early- versus late-onset, with or without severe features, HELLP syndrome, and postpartum-onset). These type of preeclampsia may also vary based on specific individual risk factors. One risk factor that researchers have identified is a woman's body mass index (aka BMI), a number calculated from a patient's height and weight.
In this study, researchers asked: are there biomarkers (molecules measured in the blood) in early pregnancy that can predict preterm preeclampsia later in pregnancy? And if so, are those biomarkers different in women in different BMI groups (healthy, overweight, obese)? Researchers found distinct levels of certain metabolites (small products of metabolism) in blood drawn in early pregnancy that were linked to developing preterm preeclampsia later in that pregnancy. Interestingly, one metabolite was a form of vitamin D (25-hydroxyvitamin D3). Others were small fatty acids and individual amino acids (the building blocks of protein). When comparing metabolites and their ratios to one another among women in different BMI groups, researchers also found among women who went on to develop preterm preeclampsia, that metabolites in early pregnancy were different depending on BMI groups, particularly for women with overweight and obesity.
Take home message: As preeclampsia research continues to move forward at an accelerated pace, research is revealing possible differences not only in “types” of preeclampsia, but also differences in maternal risk profiles. This study suggests that women of different BMI classes might have distinct risk profiles for preeclampsia. More work is needed to refine risk factors for individuals, with the ultimate goal of having an early-pregnancy screening test to predict preeclampsia.
Link: https://www.ajog.org/article/S0002-9378(22)02290-6/pdf
Citation: Tuytten R, Syngelaki A, Thomas G, Panigassi A, Brown LW, Ortea P, Nicolaides KH. First Trimester Preterm Preeclampsia Prediction with Metabolite Biomarkers: Differential Prediction According to Maternal Body Mass Index. Am J Obstet Gynecol. 2022 Dec 17:S0002-9378(22)02290-6. doi: 10.1016/j.ajog.2022.12.012. Epub ahead of print. PMID: 36539025.
Each quarter, our team of researchers reviews the most current studies related to hypertensive disorders of pregnancy and selects those studies they feel will be of greatest interest to our community to summarize.
Special thanks to our volunteer research team, who under the leadership of Dr. Elizabeth Sutton, make Research Roundup possible: Alisse Hauspurg, MD Felicia LeMoine, and MD Jenny Sones, PhD, DVM.
Development and validation of a new algorithm for improved cardiovascular risk prediction Heart disease or cardiovascular disease (CVD) is a leading cause of death worldwide. An individual&r...
Women With a History of Preeclampsia Exhibit Accelerated Aging and Unfavorable Profiles of Senescence Markers Scientists conducted a study to see if women with preeclampsia were more likely...
Feasibility of home-based treatment among participants in a remote postpartum hypertension program Postpartum hypertension (high blood pressure after pregnancy) is the most common reason for...
Postpartum Ambulatory Blood Pressure Patterns Following New-Onset Hypertensive Disorders of Pregnancy After experiencing gestational hypertension or preeclampsia, high blood pressure can wors...
Patterns of Gestational Hypertension or Preeclampsia Across 2 Pregnancies in Relationship to Chronic Hypertension Development: A Retrospective Cohort Study Experiencing preeclampsia or gestat...